Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2005

A lack of association of variants in Hemochromatosis gene with ischemic stroke.

Danish Saleheen, Umar Farooq, Philippe Frossard

Med Sci Monit 2005; 11(9): LE9-9 :: ID: 428459


Dear Editor, Stroke is a multi-factorial disorder and is a leading causeof morbidity and mortality in the World [1]. Despite extensive efforts and progress in the field, theburden of the disease is rising and is expected to continue to do so in coming years, especially in developingand underdeveloped regions of the World [2]. Identification of novel risk factors, and hence the preventionof disease, has important public health implications. Recently in a previous issue of this journal, Hruskovicovaet al. studied two variants (C282Y) and (H63D) in Hemochromatosis (HFE) gene and investigated their associationwith atherothrombotic cerebral infarction in a case control study design in Slovenia [3]. They failedto show an association with the disease. However there are certain comments and queries that need tobe addressed before ruling out HFE gene's association with the disease. There are ~37 allelic variantsthat have been identified in the HFE gene [3]. The authors of the present study have investigated onlytwo. The bases of the candidate gene based association studies relies on the principle of "Linkage disequilibrium(LD)". According to this principle, single nucleotide polymorphisms (SNP's) in a candidate gene are investigatedto find out if they are linked with an unknown functional variant within the gene. A lack of associationof two out of 37 allelic variants present with in the gene does not permit to conclude that the genecan not be implicated in the pathogenesis of the disease. Moreover, the frequency of the rare alleleof the polymorphisms investigated is too low in their study population. Thus C822Y and H63D are not informativeand not appropriate SNP's to study in Slovenian subjects. The authors should have reported LD betweenC822Y and H63D polymorphims. Based on the LD values, a diplotype analysis should have been done. Manystudies done on complex disorders have found haplotypes or diplotypes explaining the risk of diseasemore than individual SNP's [4,5]. Association studies looking at individual SNP's in association withdisease can have loss of information attributed to biallelic polymorphisms and thus can have inflatedtype-I error attributable to multiple comparisons [5]. This is avoided through analysis of a combinationof sites on specific alleles (phase on chromosomes) in association with the disease. Authors have usedthe term "mutations" for C282Y and H63D. These are polymorphisms and not mutations. Distinction betweenthe two is based on the frequency in the population with mutations having a frequency less than 1%. Analysesof the present study should be repeated before concluding a negative association of HFE gene with atherothromboticcerebral infarction. References: 1.American heart Association: Heart Disease and Stroke Statistics -2003 Update. Dallas, Tex: American Heart Association, 2002 2.World Health Organization (WHO): The atlasof heart disease and stroke. http: //www.who.int/cardiovascular_diseases/resources/atlas/en/ (accessed18 December 2004) 3.Hruskovicova H, Milanez T, Kobal J et al: Hemochromatosis-causing mutations C282Yand H63D are not risk factors for atherothrombotic cerebral infarction. Med Sci Monit. 2005; 11(7): BR248-BR2524.Drysdale CM, McGraw DW, Stack CB et al: Complex promoter and coding region beta 2-adrenergic receptorhaplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA, 2000;97(19): 10483-88 5.Jorde LB: Linkage disequilibrium and the search for complex disease genes. GenomeRes, 2000; 10(10): 1435-44.

Keywords: Brain Ischemia - genetics, genetic variation, Hemochromatosis - genetics, Intracranial Arteriosclerosis - genetics, Intracranial Thrombosis - genetics, Linkage Disequilibrium, Mutation, Risk Factors

Add Comment 0 Comments

615 3


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

05 Jun 2023 : Clinical Research  

Comparison of Texture and Color Enhancement Imaging with White Light Imaging in 52 Patients with Short-Segm...

Med Sci Monit In Press; DOI: 10.12659/MSM.940249  

05 Jun 2023 : Laboratory Research  

Comparison of Composite Resin (Duo-Shade) Shade Guide with Vita Ceramic Shades Before and After Chemical an...

Med Sci Monit In Press; DOI: 10.12659/MSM.940949  

02 Jun 2023 : Database Analysis  

The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940904  

01 Jun 2023 : Clinical Research  

Root Canal Numbers and Configurations in 1080 Permanent Canine Teeth in 270 Saudi Subjects Using Cone-Beam ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940472  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750